Fluorescent Immunoassay Market Size & Growth | Report 2028

Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, and Others)

Publication Month: May 2022 | Report Code: TIPRE00011093 | No. of Pages: 194 | Category: Biotechnology | Status: Published

The fluorescent immunoassay market was valued at US$ 2,578.66 million in 2021 and is projected to reach US$ 3,778.78 million by 2028; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.

Fluorescent immunoassays are simply a different type of immunoassay. The critical variable is the biochemical technique used to detect the binding of the "detector" antibody and the analyte molecule. Fluorescent immunoassay is a sensitive technique that can measure many compounds, including drugs, hormones, and proteins; identify antibodies; and quantify antigens such as viral particles and possibly bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. Several breakthroughs have been made in recent years that have enabled a fluorescence-based immunoassay system at the point of care. Several technical improvements have recently occurred that have allowed a susceptible immunoassay system to implement. These include the availability of narrow-wavelength, low-cost light sources, newer, more stable fluorophores with extensive Stokes shifts, stable solid-state light detectors, and microprocessors to process and analyze the data from each test. When a fluorescence detection system is connected to a lateral flow assay and combined with a powerful yet inexpensive analyzer, the result is improved assay performance.

Report Coverage

The scope of the global fluorescent immunoassay market includes product type, application, end user, and geography. The market for fluorescent immunoassay is analyzed based on regions such as North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the fluorescent immunoassay market, emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Lucrative Regions for Fluorescent Immunoassay Market

Lucrative Regions for Fluorescent Immunoassay Market

Get more information on this report :


Market Insights
Growing Prevalence of Chronic Diseases across the World.

Chronic diseases and conditions are on the rise worldwide. The need for costly chronic care is increasing, placing significant demands on healthcare systems. According to the Centers for Disease Control and Prevention (CDC), an estimated 150 million Americans had one or more chronic conditions as of 2016. According to the World Health Organization (WHO), the prevalence of chronic diseases was projected to increase by 57% in 2020. According to the National Center for Biotechnology Information (NCBI), chronic kidney disease (CKD) is the 14th leading cause of death worldwide and is responsible for 1.2 million deaths each year. Early detection and treatment are crucial, as progressive CKD is associated with unfortunate clinical consequences, including end-stage kidney disease (ESKD), cardiovascular diseases, and increased mortality. The diagnosis, prognosis, and control of chronic kidney disease are based on understanding the glomerular filtration rate (GFR). Cystatin-C is a better GFR marker than the commonly used creatinine. The fluorescence lateral flow immunoassay was developed and optimized to estimate the cystatin C value to calculate the glomerular filtration rate.

The COVID-19 pandemic highlighted the need for rapid and accurate nucleic acid detection at the point of care. Fluorescence-based quantitative reverse transcription PCR (RT-qPCR) has high sensitivity and specificity. In addition, a maximum of people infected with SARS-CoV-2 develop mild or no symptoms. There is, therefore, an urgent need to develop rapid, simple, and high-throughput assays for the detection of nucleic acids. A standard fluorescence immunoassay system is a multiparametric, random access system that provides accurate and reliable diagnostic results. It is a system capable of performing qualitative and quantitative analyses of infections, respiratory diseases, and chronic diseases. A cut-off index provides a good reference point for medical decision-making. Thus, rising incidence of COVID-19 cases and growing chronic diseases are responsible for the global fluorescent immunoassay market growth.

Product Type - Based Insights

Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. In 2021, the ELISA segment accounted for the largest share of the market. ELISA is a plate-based test technique for detecting and measuring soluble molecules such as peptides, proteins, antibodies, and hormones. The growth of this segment is attributed to the significant use of immunoassay tests to diagnose cancer, infectious illnesses, and other chronic problems. The same segment is likely to register the highest CAGR in the global fluorescent immunoassay market during the forecast period.

Global Fluorescent Immunoassay Market, by Application – 2021 & 2028

Global Fluorescent Immunoassay Market, by Application – 2021 & 2028

Get more information on this report :


Application - Based Insights

Based on application, the global fluorescent immunoassay market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious diseases segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End User – Based Insights

In terms of end user, the global fluorescent immunoassay market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals & clinics segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

The COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening, especially in developing countries across the globe, as it reduced imports due to disruptions in global trade. To date, no definitive treatment against COVID-19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the global fluorescent immunoassay market. In the long run, the fluorescent immunoassay market would have significant growth prospects as many market players had received emergency use authorization for their newly developed tests. In May 2020, ERBA Diagnostics Mannheim GmbH (Germany) launched its immunoassay-based kit—ErbaLisa COVID-19 ELISA kits to detect IgG and IgM antibodies against SARS-CoV-2. In addition, researchers developed portable devices, reagents, and standards suitable for home use. Therefore, all such developments would add up to the proliferating future demand for fluorescent immunoassays.

Companies commonly adopt product launches and expansion strategies to expand their footprint worldwide and meet the growing demand. The market players commonly adopt these strategies in order to expand their product portfolio.

The market players operating in the global fluorescent immunoassay market adopted the strategy of product innovation to cater to changing customer demand worldwide, which also permits the players to maintain their brand name globally.

  • In June 2021, F. Hoffmann-La Roche Ltd. announced that it had launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of SARS-CoV-2 infections. The laboratory-based Elecsys SARS-CoV-2 Antigen test had earlier received a CE mark and has recently obtained the import license from CDSCO.
  • In May 2021, BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes was launched to help clinicians determine the risks of Intubation with Mechanical Ventilation and mortality in COVID-19 patients, aiding in-patient management decisions. The BD Multitest 6-Color TBNK Reagent with optional BD Trucount Tubes was licensed by Health Canada as a 6-color direct immunofluorescence reagent for use with a suitably equipped BD flow cytometer to identify and determine the percentages and absolute counts of T, B, and natural killer (NK) cells, as well as the CD4 and CD8 subpopulations of T cells in peripheral blood. The BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes can be used with the BD FACS Loader and the BD FACS Universal Loader.
  • In May 2021, Ortho Clinical Diagnostics announced that its quantitative COVID-19 IgG antibody test achieved a CE Mark. Ortho’s VITROS Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization of SARS-CoV-2 serological methods.
  • In December 2020, Beckman Coulter announced the launch of a new test that addressed the three main barriers currently facing schools, businesses, hospitals, and communities with the rollout of mass COVID-19 testing. The new Access SARS-CoV-2 Antigen assay provided a high-quality, high-throughput COVID-19 test with the volume, workflow, and scalable flexibility needed to help fight the COVID-19 pandemic. The Access SARS-CoV-2 Antigen assay was offered to healthcare providers at US$ 4, making reliable and frequent mass testing affordable.

Fluorescent Immunoassay – Market Segmentation

The global fluorescent immunoassay market is segmented based on product type, application, and end user. Based on product type, the fluorescent immunoassay market is further segmented into ELISA, rapid lateral flow immunoassay, and others. In terms of application, the fluorescent immunoassay market is further segmented into infectious diseases, oncology, cardiovascular diseases, and others. Based on end user, the fluorescent immunoassay market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. By geography, the global fluorescent immunoassay market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

  • Abbott
  • BD
  • bioMerieux SA
  • F. Hoffman-La Roche Ltd.
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Quidel Corp.
  • Ortho Clinical Diagnostics Holdings plc
  • Danaher

Frequently Asked Questions

Fluorescence immunoassay is a sensitive technique that is used in the measurement of many compounds, including drugs, hormones, and proteins; in the identification of antibodies; and in the quantification of antigens such as viral particles and, potentially, bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. A modern fluorescent-based immunoassay uses as the detection reagent a fluorescent compound that absorbs light or energy (excitation energy) at a specific wavelength and then emits light or energy at a different wavelength.
The factors that are driving the growth of the market are the growing prevalence of chronic diseases and increasing demand for cell therapies are expected to boost the growth of the global fluorescent immunoassay market.
The fluorescent immunoassay market majorly consists of the players such as Abbott, BD, bioMerieux SA, F. Hoffman-La Roche Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Quidel Corp., Ortho Clinical Diagnostics Holdings plc, Danaher and among others.
The ELISA segment dominated the global fluorescent immunoassay market and held the largest market share of 56.12% in 2021.
The infectious diseases segment dominated the global fluorescent immunoassay market and held the largest market share of 54.39% in 2021.
The hospitals & clinics segment dominated the global fluorescent immunoassay market and held the largest market share of 43.16% in 2021.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Fluorescent Immunoassay Market – By Product Type

1.3.2 Fluorescent Immunoassay Market – By Application

1.3.3 Fluorescent Immunoassay Market – By End User

1.3.4 Global Fluorescent Immunoassay Market – By Geography

2. Fluorescent Immunoassay Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Fluorescent Immunoassay Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America– PEST Analysis

4.3 Expert Opinions

5. Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Chronic Diseases

5.1.2 Increasing Demand for Cell Therapies

5.2 Market Restraints

5.2.1 Disadvantages of Fluorescent Immunoassays

5.3 Market Opportunities

5.3.1 Extensive Usage in Cancer Diagnostics

5.4 Future Trends

5.4.1 Increase in Development of Fluorescent Dyes and Instruments

5.5 Impact Analysis

6. Fluorescent Immunoassay Market – Global Analysis

6.1 Global Fluorescent Immunoassay Marker Revenue Forecast and Analysis

6.1.1 Global Fluorescent Immunoassay Market, By Geography - Forecast And Analysis

6.1.2 Global Fluorescent Immunoassay Market – Market Potential Analysis, By Region

6.1.3 Market Share Analysis of Fluorescent Immunoassay Market

6.2 Company Analysis

6.2.1 Market Positioning of Key Players

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance Of Key Players

6.2.4.1 F. Hoffman-La Roche Ltd.

6.2.4.2 Thermo Fisher Scientific Inc.

7. Fluorescent Immunoassay Market Analysis and Forecasts to 2028 Product Type

7.1 Overview

7.2 Global Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)

7.3 ELISA

7.3.1 Overview

7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.4 Rapid Lateral Flow Immunoassay

7.4.1 Overview

7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8. Fluorescent Immunoassay Market Analysis – By Application

8.1 Overview

8.2 Global Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)

8.3 Infectious Diseases

8.3.1 Overview

8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.5 Cardiovascular Disease

8.5.1 Overview

8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9. Fluorescent Immunoassay Market – By End User

9.1 Overview

9.2 Global Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals & Clinics

9.3.1 Overview

9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.4 Diagnostic Centers

9.4.1 Overview

9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.5 Pharmaceutical & Biotechnology Companies

9.5.1 Overview

9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.6 Academic & Research Institutes

9.6.1 Overview

9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

10. Fluorescent Immunoassay Market Analysis and Forecasts To 2028 Geographical Analysis

10.1 North America: Fluorescent Immunoassay Market

10.1.1 Overview

10.1.2 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.3 North America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.4 North America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.5 North America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

10.1.6.1 US: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.6.1.3 US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.4 US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.5 US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6.2 Canada: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.6.2.3 Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.4 Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.5 Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.6.3 Mexico: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.1.6.3.3 Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.4 Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.5 Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2 Europe: Fluorescent Immunoassay Market

10.2.1 Overview

10.2.2 Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.2.1.1 Europe: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.2.2.1.2 Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.2.1.3 Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

10.2.3.1 Germany: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.2.3.1.1 Overview

10.2.3.1.2 Germany: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.3.1.3 Germany: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.2.3.1.4 Germany: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.1.5 Germany: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.3.2 UK: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.2.3.2.1 Overview

10.2.3.2.2 UK: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.3.2.3 UK: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.2.3.2.4 UK: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.2.5 UK: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.3.3 France: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.2.3.3.1 Overview

10.2.3.3.2 France: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.3.3.3 France: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.2.3.3.4 France: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.3.5 France: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.3.4 Italy: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.2.3.4.1 Overview

10.2.3.4.2 Italy: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.3.4.3 Italy: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.2.3.4.4 Italy: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.4.5 Italy: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.3.5 Spain: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.2.3.5.1 Overview

10.2.3.5.2 Spain: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.3.5.3 Spain: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.2.3.5.4 Spain: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.5.5 Spain: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.2.3.6 Rest of Europe: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)

10.2.3.6.1 Overview

10.2.3.6.2 Rest of Europe: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.2.3.6.3 Rest of Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.6.4 Rest of Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.2.3.6.5 Rest of Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3 Asia Pacific: Fluorescent Immunoassay Market

10.3.1 Overview

10.3.2 Asia Pacific: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia-Pacific: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.4 Asia-Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.5 Asia-Pacific: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3.6 Asia Pacific: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.1 China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.2 China Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.3 China: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.4 China: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3.6.2 Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.1 Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.2 Japan: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.3 Japan: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.4 Japan: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3.6.3 India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.1 India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.2 India: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.3 India: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.4 India: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3.6.4 South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.1 South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.2 South Korea: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.3 South Korea: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.4 South Korea: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3.6.5 Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.1 Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.2 Australia: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.3 Australia: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.4 Australia: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.3.6.6 Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.1 Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.2 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.3 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.4 Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4 Middle East & Africa: Fluorescent Immunoassay Market

10.4.1 Overview

10.4.2 Middle East & Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)

10.4.3 Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.4.4 Middle East & Africa Fluorescent Immunoassay Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.4.5 Middle East & Africa Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.4.6 Middle East & Africa Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)

10.4.6.1 Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.1 Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.2 Saudi Arabia Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.3 Saudi Arabia Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.4 Saudi Arabia Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6.2 UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.1 UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.2 UAE: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.3 UAE: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.4 UAE: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6.3 South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.1 South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.2 South Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.3 South Africa Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.4 South Africa Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.4.6.4 Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.1 Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.2 Rest of Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.3 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.4.6.4.4 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.5 South and Central America: Fluorescent Immunoassay Market

10.5.1 Overview

10.5.2 South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.5.2.1.1 South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.5.2.1.2 South and Central America: Fluorescent Immunoassay Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.5.2.1.3 South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.5.3 South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

10.5.3.1 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.5.3.1.1 Overview

10.5.3.1.2 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.5.3.1.3 Brazil: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.5.3.1.4 Brazil: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.5.3.1.5 Brazil: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million

10.5.3.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.5.3.2.1 Overview

10.5.3.2.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

10.5.3.2.3 Argentina: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.5.3.2.4 Argentina: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.5.3.3 Rest of South and Central America: Fluorescent Immunoassay Market– Revenue and Forecast to 2028 (USD Mn)

10.5.3.3.1 Overview

10.5.3.3.2 Rest of South and Central America: Fluorescent Immunoassay Market– Revenue and Forecast to 2028 (USD Mn)

10.5.3.3.3 Rest of South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.5.3.3.4 Rest of South and Central America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.5.3.3.5 Rest of South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Fluorescent Immunoassay Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Fluorescent Immunoassay Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 F. HOFFMANN-LA ROCHE LTD.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 THERMO FISHER SCIENTIFIC INC.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Abbott

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 BD

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Danaher

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 bioMerieux SA

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Sysmex Corporation

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Siemens AG

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Ortho Clinical Diagnostics Holdings plc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Quidel Corporation

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 2. US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 3. US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4. Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10. Europe: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Germany: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Germany: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 15. Germany: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 16. UK: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 17. UK: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 18. UK: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 19. France: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 20. France: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21. France: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Italy: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Italy: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24. Italy: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25. Spain: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 26. Spain: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 27. Spain: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of Europe: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 31. Asia-Pacific: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 32. Asia-Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 33. Asia-Pacific: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 34. China: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 35. China: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 36. China: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 37. Japan: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 38. Japan: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 39. Japan: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 40. India: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 41. India: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 42. India: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 43. South Korea: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 44. South Korea: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 45. South Korea: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 46. Australia: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 47. Australia: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 48. Australia: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 49. Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 50. Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 51. Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 52. Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 53. Middle East & Africa Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 54. Middle East & Africa Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 55. Saudi Arabia Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 56. Saudi Arabia Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 57. Saudi Arabia Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 58. UAE: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 59. UAE: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 60. UAE: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 61. South Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 62. South Africa Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million

Table 63. South Africa Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 64. Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 65. Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 66. Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 67. South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 68. South and Central America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 69. South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 70. Brazil: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 71. Brazil: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 72. Brazil: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 73. Argentina: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 74. Argentina: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Argentina: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 75. Argentina: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 76. Rest of South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 77. Rest of South and Central America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 78. Rest of South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 79. Organic Developments in the Fluorescent Immunoassay Market

Table 80. Inorganic Developments in the Fluorescent Immunoassay Market

Table 81. Glossary of Terms, Fluorescent Immunoassay Market

LIST OF FIGURES

Figure 1. Fluorescent Immunoassay Market Segmentation

Figure 2. Fluorescent Immunoassay Market – By Geography

Figure 3. Fluorescent Immunoassay Market Overview

Figure 4. ELISA by Product Type Held Largest Share of Fluorescent Immunoassay Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Fluorescent Immunoassay Market, by Geography (USD Million)

Figure 7. Global Fluorescent Immunoassay Market – Leading Country Markets (USD Million)

Figure 8. Global Fluorescent Immunoassay Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East & Africa PEST Analysis

Figure 13. South & Central America PEST Analysis

Figure 14. Global Fluorescent Immunoassay Market Impact Analysis of Driver and Restraints

Figure 15. Global Fluorescent Immunoassay Market – Revenue Forecast And Analysis – 2020- 2028

Figure 16. Global Fluorescent Immunoassay Market – By Geography Forecast and Analysis – 2021- 2028

Figure 17. Global Fluorescent Immunoassay Market – Market Potential Analysis, By Region

Figure 18. Market Share Analysis of Key Players in Global Fluorescent Immunoassay Market

Figure 19. Market Positioning Of Key Players In Global Fluorescent Immunoassay Market

Figure 20. Global Fluorescent Immunoassay Market – Comparative Company Analysis

Figure 21. Global Fluorescent Immunoassay Market – Growth Strategy Analysis

Figure 22. Global Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)

Figure 23. ELISA: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 24. Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 25. Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 26. Global Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)

Figure 27. Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 28. Most Prevalent Forms of Cancers Globally, 2020

Figure 29. Oncology: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 30. Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 31. Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 32. Global Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)

Figure 33. Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 34. Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 35. Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 36. Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 37. Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)

Figure 38. North America Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 39. North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 40. North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

Figure 41. US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 42. Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 43. Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 44. Europe Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 45. Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 46. Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

Figure 47. Germany: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 48. UK: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 49. France: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 50. Italy: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 51. Spain: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 52. Rest of Europe: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 53. Asia Pacific: Fluorescent Immunoassay Market, by Key Country – Revenue (2021) (USD Million)

Figure 54. Asia Pacific Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

Figure 55. Asia Pacific: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)

Figure 56. China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 58. India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 61. Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 62. Middle East & Africa: Fluorescent Immunoassay Market, by Key Country – Revenue (2021) (USD Million)

Figure 63. Middle East & Africa Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

Figure 64. Middle East & Africa: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)

Figure 65. Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 66. UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 68. Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

Figure 69. South and Central America Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 70. South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 71. South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)

Figure 72. Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 73. Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)

Figure 74. Rest of South and Central America: Fluorescent Immunoassay Market– Revenue and Forecast to 2028 (USD Mn)

Figure 75. Impact of COVID-19 Pandemic in North American Country Markets

Figure 76. Impact of COVID-19 Pandemic in European Country Markets

Figure 77. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 78. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

Figure 79. Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 80. Growth Strategies in the Fluorescent Immunoassay Market (%)

The List of Companies - Fluorescent Immunoassay Market

  1. Thermo Fisher Scientific
  2. Abbott Laboratories
  3. Ortho Clinical Diagnostics
  4. BD
  5. F. Hoffmann La Roche
  6. Danaher
  7. bioMérieux SA
  8. Siemens AG
  9. Sysmex
  10. Quidel Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the fluorescent immunoassay market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global fluorescent immunoassay market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00011093
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount